Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: William Marsh who wrote (92)	9/19/1999 5:47:00 PM
From: William Marsh	Read Replies (1) \| Respond to of 236

The September 13th New Yorker has an article about the papilloma virus, cervical dysplasia, cervical cancer and anal cancer. It does not mention SSB, other than this oblique comment towards the end: "There are also attempts to develop a so-called therapeutic vaccine, which would boost the immune system of someone who was already infected. Such vaccines would target the E6 and E7 proteins, those viral proteins that sabotage cell-growth regulation." However, the article gives a very good idea of the nature and size of the potential market for SSBs vaccines, should they prove effective.